Renalytix Market Cap

Renalytix has a market cap or net worth of 7.87 million as of April 28, 2026. Its market cap has decreased by -70.31% in one year.

Market Cap

7.87M

Enterprise Value

7.57M

Revenue

2.45M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.80

Market Cap Chart

Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 7.87M, a decrease of -87.82%. That is a compound annual growth rate of -24.54%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	7.87M	-69.49%
Dec 31, 2025	25.78M	-27.58%
Dec 31, 2024	35.60M	129.87%
Dec 29, 2023	15.49M	-71.47%
Dec 30, 2022	54.30M	-87.89%
Dec 31, 2021	448.32M	27.67%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	216.46B
GSK plc	80.48B
Haleon	31.17B
Smith & Nephew	10.09B
CelLBxHealth	10.80M
Oxford BioDynamics	9.44M
GENinCode	8.47M
Cizzle Biotechnology Holdings	8.32M

Market Cap Rankings